Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density.
Eriksson R, Broberg BV, Ishøy PL, Bak N, Andersen UB, Jørgensen NR, Knop FK, Ebdrup BH. Eriksson R, et al. Among authors: ishoy pl. Front Psychiatry. 2019 Jan 28;9:781. doi: 10.3389/fpsyt.2018.00781. eCollection 2018. Front Psychiatry. 2019. PMID: 30745885 Free PMC article.
Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist--protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol.
Ishøy PL, Knop FK, Broberg BV, Baandrup L, Fagerlund B, Jørgensen NR, Andersen UB, Rostrup E, Glenthøj BY, Ebdrup BH. Ishøy PL, et al. BMJ Open. 2014 Jan 8;4(1):e004158. doi: 10.1136/bmjopen-2013-004158. BMJ Open. 2014. PMID: 24401727 Free PMC article. Clinical Trial.
Erratum: Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: A randomized, placebo-controlled trial.
Ebdrup BH, Broberg BV, Ishøy PL, Bak N, Andersen UB, Jørgensen NR, Holst JJ, Knop FK, Glenthøj BY. Ebdrup BH, et al. Among authors: ishoy pl. Diabetes Obes Metab. 2018 May;20(5):1327-1328. doi: 10.1111/dom.13204. Epub 2018 Jan 23. Diabetes Obes Metab. 2018. PMID: 29316175 Free PMC article. No abstract available.
Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis.
Siskind D, Hahn M, Correll CU, Fink-Jensen A, Russell AW, Bak N, Broberg BV, Larsen J, Ishøy PL, Vilsbøll T, Knop FK, Kisely S, Ebdrup BH. Siskind D, et al. Among authors: ishoy pl. Diabetes Obes Metab. 2019 Feb;21(2):293-302. doi: 10.1111/dom.13522. Epub 2018 Oct 7. Diabetes Obes Metab. 2019. PMID: 30187620
11 results